Filing Details

Accession Number:
0001567619-18-007048
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-11-28 17:09:50
Reporting Period:
2018-11-26
Accepted Time:
2018-11-28 17:09:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1581720 Loxo Oncology Inc. LOXO Pharmaceutical Preparations (2834) 462996673
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640069 Jennifer Burstein C/O Loxo Oncology, Inc.
One Landmark Square, Suite 1122
Stamford CT 06901
Senior Vp Of Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-11-26 1,250 $11.35 1,250 No 4 M Direct
Common Stock Disposition 2018-11-26 500 $151.57 750 No 4 S Direct
Common Stock Disposition 2018-11-26 250 $152.39 500 No 4 S Direct
Common Stock Disposition 2018-11-26 100 $153.30 400 No 4 S Direct
Common Stock Disposition 2018-11-26 300 $155.13 100 No 4 S Direct
Common Stock Disposition 2018-11-26 100 $156.04 0 No 4 S Direct
Common Stock Acquisiton 2018-11-27 1,250 $11.35 1,250 No 4 M Direct
Common Stock Disposition 2018-11-27 200 $137.89 1,050 No 4 S Direct
Common Stock Disposition 2018-11-27 350 $138.95 700 No 4 S Direct
Common Stock Disposition 2018-11-27 200 $140.94 500 No 4 S Direct
Common Stock Disposition 2018-11-27 200 $143.84 300 No 4 S Direct
Common Stock Disposition 2018-11-27 100 $147.09 200 No 4 S Direct
Common Stock Disposition 2018-11-27 100 $148.20 100 No 4 S Direct
Common Stock Disposition 2018-11-27 100 $151.55 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2018-11-26 1,250 $0.00 1,250 $11.35
Common Stock Employee Stock Option (Right to Buy) Disposition 2018-11-27 1,250 $0.00 1,250 $11.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
21,250 2025-04-30 No 4 M Direct
20,000 2025-04-30 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
  2. Represents the aggregate of sales effected on the same day at different prices.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.09 to $152.08 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.21 to $152.61 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $154.69 to $155.37. per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.63 to $138.15 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.68 to $139.10 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.64 to $141.24 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.54 to $144.14 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.13 to $148.24 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. The stock option vests and becomes exercisable as to 25% of the shares subject to the option on the one-year anniversary of the Reporting Person's employment commencement date, and thereafter vests as to 1/48th of the shares in equal monthly installments.